文献速递免疫规划卫生政策与健康促进

CIOMS疫苗安全沟通指南执行摘要解读

CIOMS Guide To Vaccine Safety Communication - Executive summary.
PubMed 文献 · Vaccine · 2018-12-13

2018年CIOMS发布《疫苗安全沟通指南》,由国际多利益相关方工作组制定,旨在支持WHO全球疫苗安全倡议。指南强调监管机构在疫苗犹豫和知情选择背景下应建立具备明确职能和熟练人员的沟通系统,并支持适配当地疫苗类型的疫苗安全沟通计划(VacSCP)。该指南尤其面向资源有限国家的监管机构,也可供其他利益相关方参考。

要点

  • 监管机构需透明公开疫苗质量、安全性和有效性评估数据。
  • 监管机构负责持续安全监测并保持安全使用建议更新。
  • 指南提供系统组件建议和实用VacSCP模板。

核心结论

  • 指南有助于全球监管机构加强疫苗安全沟通,尤其面向资源有限国家。

研究设计与样本

  • 由CIOMS国际多利益相关方疫苗安全工作组制定,基于现有指南及新研究综述和经验汇编,以支持WHO全球疫苗安全倡议。

主要发现

  • 监管机构在疫苗安全沟通中具有独立角色,需透明公开质量、安全性和有效性评估数据。
  • 监管机构负责持续安全监测并保持安全使用建议更新。
  • 指南强调监管机构应建立具有明确职能和熟练人员的系统,以高效开展疫苗安全沟通。
  • 该系统应采取战略沟通方法,融入安全监测和风险评估,并支持适配当地疫苗类型的VacSCP。
  • 指南提供系统组件建议、示例及实用VacSCP模板。

临床怎么用

  • 监管机构可参照指南建立或完善疫苗安全沟通系统,并制定适配本地疫苗类型的VacSCP。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2018, the Council for International Organizations of Medical Sciences (CIOMS) issued their Guide to Vaccine Safety Communication. This has been built upon existing guidance and a new review of research and compilation of latest experiences, in order to fill, for the first time at global level, a specific niche for regulatory authorities in the contexts of vaccine hesitancy and informed choice. The Guide was developed by the international multi-stakeholder CIOMS Working Group on Vaccine Safety, formed to assist the Global Vaccine Safety Initiative (GVSI) of the World Health Organization (WHO). SUMMARY: Besides the public health authorities responsible for immunization programmes, regulators have their own role in communicating about vaccine safety. As they are responsible for licensing vaccine products, they need to be transparent about their assessments of data on quality, safety and efficacy. Furthermore, they are responsible for continuous safety surveillance and keeping safe use advice to the public up-to-date. The Guide stresses the fundamental importance of regulatory bodies to have a system in place with defined functions and skilled persons who can efficiently run vaccine safety communication in collaboration with stakeholders. This system should take a strategic approach to communication, be integral to safety surveillance and risk assessment, and support vaccine safety communication plans (VacSCPs) adapted to vaccine types in local situations. The Guide provides recommendations and examples for the system components as well as a practical VacSCP template. CONCLUSIONS: While the Guide should help strengthening regulatory bodies worldwide with regard to vaccine safety communication, it is meant to help regulators in resource-limited countries in particular. It can also be of interest to other stakeholders and be leveraged to other medicinal products.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bahri P, Rägo L. CIOMS Guide To Vaccine Safety Communication - Executive summary. Vaccine. 2018. PMID: 30554796. doi:10.1016/j.vaccine.2018.11.082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。